Carregant...
A Proposed Methodology for a Risk Assessment-Based Liposome Development Process
The requirements of a liposomal formulation vary depending on the pharmaceutical indication, the target patient population, and the corresponding route of administration. Different preparation methods require various material attributes (MAs) (properties and characteristics of the components) and pr...
Guardat en:
| Publicat a: | Pharmaceutics |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7760874/ https://ncbi.nlm.nih.gov/pubmed/33260443 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12121164 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|